Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes
- 14 July 2020
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 114 (3) , 567-578
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Impact of grandmultiparity on obstetric outcome in low resource settingJournal of Obstetrics and Gynaecology Research, 2011
- Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcomeFertility and Sterility, 2010
- Neonatal outcome associated with singleton birth at 34-41 weeks of gestationInternational Journal of Epidemiology, 2010
- Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndromeHuman Reproduction Update, 2008
- Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilizationFertility and Sterility, 2006
- Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*Acta Obstetricia et Gynecologica Scandinavica, 2005
- Obstetric and Neonatal Outcomes in Grand MultiparityObstetrics & Gynecology, 2004
- US Birth Weight/Gestational Age-Specific Neonatal Mortality: 1995–1997 Rates for Whites, Hispanics, and BlacksPediatrics, 2003
- Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilizationFertility and Sterility, 1999
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994